Cargando…

The 2015 global production capacity of seasonal and pandemic influenza vaccine

A global shortage and inequitable access to influenza vaccines has been cause for concern for developing countries who face dire consequences in the event of a pandemic. The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 to increase global capacity for influenza vaccine product...

Descripción completa

Detalles Bibliográficos
Autores principales: McLean, Kenneth A., Goldin, Shoshanna​, Nannei, Claudia, Sparrow, Erin, Torelli, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357707/
https://www.ncbi.nlm.nih.gov/pubmed/27531411
http://dx.doi.org/10.1016/j.vaccine.2016.08.019
_version_ 1782516088384258048
author McLean, Kenneth A.
Goldin, Shoshanna​
Nannei, Claudia
Sparrow, Erin
Torelli, Guido
author_facet McLean, Kenneth A.
Goldin, Shoshanna​
Nannei, Claudia
Sparrow, Erin
Torelli, Guido
author_sort McLean, Kenneth A.
collection PubMed
description A global shortage and inequitable access to influenza vaccines has been cause for concern for developing countries who face dire consequences in the event of a pandemic. The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 to increase global capacity for influenza vaccine production to address these concerns. It is widely recognized that well-developed infrastructure to produce seasonal influenza vaccines leads to increased capacity to produce pandemic influenza vaccines. This article summarizes the results of a survey administered to 44 manufacturers to assess their production capacity for seasonal influenza and pandemic influenza vaccine production. When the GAP was launched in 2006, global production capacity for seasonal and pandemic vaccines was estimated to be 500 million and 1.5 billion doses respectively. Since 2006 there has been a significant increase in capacity, with the 2013 survey estimating global capacity at 1.5 billion seasonal and 6.2 billion pandemic doses. Results of the current survey showed that global seasonal influenza vaccine production capacity has decreased since 2013 from 1.504 billion doses to 1.467 billion doses. However, notwithstanding the overall global decrease in seasonal vaccine capacity there were notable positive changes in the distribution of production capacity with increases noted in South East Asia (SEAR) and the Western Pacific (WPR) regions, albeit on a small scale. Despite a decrease in seasonal capacity, there has been a global increase of pandemic influenza vaccine production capacity from 6.2 billion doses in 2013 to 6.4 billion doses in 2015. This growth can be attributed to a shift towards more quadrivalent vaccine production and also to increased use of adjuvants. Pandemic influenza vaccine production capacity is at its highest recorded levels however challenges remain in maintaining this capacity and in ensuring access in the event of a pandemic to underserved regions.
format Online
Article
Text
id pubmed-5357707
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-53577072017-03-28 The 2015 global production capacity of seasonal and pandemic influenza vaccine McLean, Kenneth A. Goldin, Shoshanna​ Nannei, Claudia Sparrow, Erin Torelli, Guido Vaccine Article A global shortage and inequitable access to influenza vaccines has been cause for concern for developing countries who face dire consequences in the event of a pandemic. The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 to increase global capacity for influenza vaccine production to address these concerns. It is widely recognized that well-developed infrastructure to produce seasonal influenza vaccines leads to increased capacity to produce pandemic influenza vaccines. This article summarizes the results of a survey administered to 44 manufacturers to assess their production capacity for seasonal influenza and pandemic influenza vaccine production. When the GAP was launched in 2006, global production capacity for seasonal and pandemic vaccines was estimated to be 500 million and 1.5 billion doses respectively. Since 2006 there has been a significant increase in capacity, with the 2013 survey estimating global capacity at 1.5 billion seasonal and 6.2 billion pandemic doses. Results of the current survey showed that global seasonal influenza vaccine production capacity has decreased since 2013 from 1.504 billion doses to 1.467 billion doses. However, notwithstanding the overall global decrease in seasonal vaccine capacity there were notable positive changes in the distribution of production capacity with increases noted in South East Asia (SEAR) and the Western Pacific (WPR) regions, albeit on a small scale. Despite a decrease in seasonal capacity, there has been a global increase of pandemic influenza vaccine production capacity from 6.2 billion doses in 2013 to 6.4 billion doses in 2015. This growth can be attributed to a shift towards more quadrivalent vaccine production and also to increased use of adjuvants. Pandemic influenza vaccine production capacity is at its highest recorded levels however challenges remain in maintaining this capacity and in ensuring access in the event of a pandemic to underserved regions. Elsevier Science 2016-10-26 /pmc/articles/PMC5357707/ /pubmed/27531411 http://dx.doi.org/10.1016/j.vaccine.2016.08.019 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
McLean, Kenneth A.
Goldin, Shoshanna​
Nannei, Claudia
Sparrow, Erin
Torelli, Guido
The 2015 global production capacity of seasonal and pandemic influenza vaccine
title The 2015 global production capacity of seasonal and pandemic influenza vaccine
title_full The 2015 global production capacity of seasonal and pandemic influenza vaccine
title_fullStr The 2015 global production capacity of seasonal and pandemic influenza vaccine
title_full_unstemmed The 2015 global production capacity of seasonal and pandemic influenza vaccine
title_short The 2015 global production capacity of seasonal and pandemic influenza vaccine
title_sort 2015 global production capacity of seasonal and pandemic influenza vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357707/
https://www.ncbi.nlm.nih.gov/pubmed/27531411
http://dx.doi.org/10.1016/j.vaccine.2016.08.019
work_keys_str_mv AT mcleankennetha the2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT goldinshoshanna the2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT nanneiclaudia the2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT sparrowerin the2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT torelliguido the2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT mcleankennetha 2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT goldinshoshanna 2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT nanneiclaudia 2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT sparrowerin 2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine
AT torelliguido 2015globalproductioncapacityofseasonalandpandemicinfluenzavaccine